Somatic Mutations of the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitor Response to TKIs in Non-small Cell Lung Cancer: An Analytical Database-Reference-Cited by-同舟云学术

Somatic Mutations of the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor and Tyrosine Kinase Inhibitor Response to TKIs in Non-small Cell Lung Cancer: An Analytical Database

Published:2008-08 Issue:8 Volume:3 Page:832-839
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Murray Samuel,Dahabreh Issa J.,Linardou Helena,Manoloukos Menelaos,Bafaloukos Dimitrios,Kosmidis Paris

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. Epidermal growth factor receptor mutations, small-molecule kinase inhibitors and non-small cell lung cancer: current knowledge and future directions;Pao;J Clin Oncol,2005

2. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (the IDEAL 1 trial) [corrected];Fukuoka;J Clin Oncol,2003

3. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial;Kris;JAMA,2003

4. Erlotinib in previously treated non-small cell lung cancer;Shepherd;N Engl J Med,2005

5. United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets;Cohen;Clin Cancer Res,2004

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutations;International Journal of Clinical Oncology;2024-08-27

2. Clinical application of whole-genome sequencing of solid tumors for precision oncology;Experimental & Molecular Medicine;2024-08-13

3. Osimertinib Resistance via Histologic Transformation From Non-small Cell Lung Carcinoma to Carcinosarcoma;Cureus;2024-04-29

4. Current management of uncommon EGFR mutations in non-small cell lung cancer;Current Problems in Cancer;2024-04

5. Clinical application of whole-genome sequencing for precision oncology of solid tumors;2024-02-14